Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
Y - Young Investigator & First Time Attendee Session
- Type: Other Sessions
- Track: Other Topics
- Presentations: 8
- Moderators:M. Edelman
- Coordinates: 10/27/2013, 08:00 - 11:30, Parkside Ballroom A+B, Level 1
-
+
Y.5 - Using the Published Literature Effectively
09:20 - 09:50 | Author(s): M. Stockler
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.12 - Poster Session 1 - NSCLC Early Stage
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 23
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.12-010 - Lung cancer clinicians' preferences for adjuvant chemotherapy (ACT) in non-small-cell lung cancer (NSCLC): what makes it worthwhile?
09:30 - 09:30 | Author(s): S. McLachlan
- Abstract
Loading... -
+
P1.12-011 - Patients' preferences for adjuvant chemotherapy (ACT) in early non-small cell lung cancer (NSCLC): What makes it worthwhile?
09:30 - 09:30 | Author(s): S. McLachlan
- Abstract
Loading...
-
+
O07 - Supportive and Surgical Care
- Type: Oral Abstract Session
- Track: Surgery
- Presentations: 8
- Moderators:M. Culligan
- Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Gallery A, Level 1
-
+
O07.02 - The preferred and actual levels of involvement in decision-making among patients considering adjuvant chemotherapy (ACT) for non-small-cell lung cancer (NSCLC).
10:40 - 10:50 | Author(s): P. Blinman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O07.04 - DISCUSSANT
11:00 - 11:15 | Author(s): M. Stockler
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PC01 - Clinical Trial Design for Drug Development
- Type: Pro/Con Session
- Track: Statistics
- Presentations: 3
- Moderators:N. Yamaguchi
- Coordinates: 10/28/2013, 14:00 - 15:30, Parkside Ballroom B, Level 1
-
+
PC01.1 - Case Introduction
14:00 - 14:10 | Author(s): M. Redman
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC01.2 - Adaptive Designs: For
14:10 - 14:50 | Author(s): J..J. Lee
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PC01.3 - Adaptive Designs: Against
14:50 - 15:30 | Author(s): M. Buyse
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-040 - Prognostic significance, accuracy and usefulness of oncologists' estimates of survival time for patients starting first-line chemotherapy for advanced non-small-cell lung cancer (ANSCLC)
09:30 - 09:30 | Author(s): B.E. Kiely
- Abstract
Loading...